| Original language | English (US) |
|---|---|
| Pages (from-to) | 1191-1193 |
| Number of pages | 3 |
| Journal | Hepatology |
| Volume | 68 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2018 |
Fingerprint
Clustered Regularly Interspaced Short Palindromic Repeats
Epigenomics
Transcriptional Activation
Therapeutics
ASJC Scopus subject areas
- Hepatology
Cite this
Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo : A new potential therapeutic modality. / Ibrahim, Samar C; Robertson, Keith D.
In: Hepatology, Vol. 68, No. 3, 01.09.2018, p. 1191-1193.Research output: Contribution to journal › Article
Ibrahim, SC & Robertson, KD 2018, 'Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality', Hepatology, vol. 68, no. 3, pp. 1191-1193. https://doi.org/10.1002/hep.29860
@article{06bf824cb8394672bd8a3fd036510a95,
title = "Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality",
author = "Ibrahim, {Samar C} and Robertson, {Keith D}",
year = "2018",
month = "9",
day = "1",
doi = "10.1002/hep.29860",
language = "English (US)",
volume = "68",
pages = "1191--1193",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",
}
TY - JOUR
T1 - Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo
T2 - A new potential therapeutic modality
AU - Ibrahim, Samar C
AU - Robertson, Keith D
PY - 2018/9/1
Y1 - 2018/9/1
UR - http://www.scopus.com/inward/record.url?scp=85047525907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047525907&partnerID=8YFLogxK
U2 - 10.1002/hep.29860
DO - 10.1002/hep.29860
M3 - Article
C2 - 29489018
AN - SCOPUS:85047525907
VL - 68
SP - 1191
EP - 1193
JO - Hepatology
JF - Hepatology
SN - 0270-9139
IS - 3
ER -